Discover the GLP-1 analogues market's expansion to US$299.08 billion by 2033 with 17.6% CAGR. Key insights on North America's 42.5% share, long-acting agonists' dominance, and applications in diabetes and obesity fueled by oral formulations and combination therapies. https://finance.yahoo.com/news/glucagon-peptide-1-analogues-market-140100995.html